<DOC>
	<DOCNO>NCT01013779</DOCNO>
	<brief_summary>A Phase II Study design evaluate efficacy Chemo-Radiotherapy achieve loco-regional control patient Merkel Cell Carcinoma ( MCC ) skin . Patients undergo PET scan assist stag plan patient 's treatment well assess response conclusion treatment .</brief_summary>
	<brief_title>Merkel Positron Emission Tomography ( PET ) Protocol</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Merkel Cell</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<criteria>Inclusion Criteria Trial Registration : Patients may register trial meet follow criterion : Age 18 year old Written inform consent participate study Able undergo 18FDG PET scan ( uncontrolled diabetes mellitus severe claustrophobia ) . Available followup . Using adequate contraception capable child bear Any Merkel Cell carcinoma confine primary and/or nodal sit ECOG 02 . Full Blood Count ( FBC ) satisfactory ( Haemoglobin &gt; equal 10g/dl , neutrophil &gt; equal 2.0 x 109 /l platelet &gt; equal 100 x 109 /l ) renal function ( GFR &gt; equal 50 ml/min ) hepatic function ( ALT &lt; 5 X upper limit normal , bilirubin &lt; 1.5 X upper limit normal ) Patients must able tolerate protocol treatment Exclusion Criteria Registration : Previous chemotherapy past 5 year prior radiotherapy area concern Unable comply treatment protocol eg dementia Other malignancy past 5 year nonmelanoma skin cancer . Women pregnant lactating . Clinical evidence metastatic disease . Immunosuppression long term steroid use immunosuppressive drug . Any serious illness medical condition precludes safe administration chemotherapy include : 1 . Active infection 2 . Uncontrolled unstable cardiac disease include unstable angina , myocardial infarction within last 3 month , recurrent ventricular arrhythmia Inclusion Criteria Treatment Registration : Patients may proceed protocol treatment meet follow criterion : High risk disease evidence distant spread : Biopsy proven MCC primary &gt; 2cm ( T2N0M0= Stage II ) and/or regional node ( T , N1M0= Stage III ) ; OR Recurrent MCC previously treat radiation treatment ; Dermal intransit metastasis without node ; Occult primary involve nodes Patients metastases CT PET scan OR If CT suggestive metastasis , must PET negative</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Merkel Cell Cancer</keyword>
	<keyword>PET scan</keyword>
</DOC>